PROS1 and breast cancer: Regarding BC-PIV/S-2PM, cross-presentation of the S protein on the vector envelope as well as processed S-derived peptides after translation in antigen-presenting cells would contribute to inducing CTL activity in humans, where hPIV2 genes are to be abundantly transcribed (Hara et al., 2013).